Zhou Ping, Jin Yonghua, Li Chao. Policy Support and Project Considerations for Pediatric Drug Development in China. [J]. 30(1):27-32(2024)
DOI:
Zhou Ping, Jin Yonghua, Li Chao. Policy Support and Project Considerations for Pediatric Drug Development in China. [J]. 30(1):27-32(2024) DOI: 10.13407/j.cnki.jpp.1672-108X.2024.01.008.
Policy Support and Project Considerations for Pediatric Drug Development in China
Objective: The current issues in children’s medication are prominent in China
characterized by a limited variety of suitable drugs
a lack of appropriate dosage forms and specifications for children
and off-label drug use. In recent years
drug regulatory authorities have issued multiple support policies and guiding principles for pediatric drug development in China
leading to an increasing enthusiasm for research and development among enterprises. This article reviews the relevant supporting policies for domestic pediatric drug development
attempts to propose directions for the initiation of pediatric drug projects from the perspective of enterprises
and analyzes the issues that need attention in research and development initiation.
Analysis of 36 Cases of Drug Poisoning in Children in a Grade III, Level A General Hospital andConsideration on Pharmaceutical Care
Application of Dexmedetomidine Combined with Hydromorphone Nasal Drip in Sedation of Mother-InfantSeparation before Adenoidectomy
Sirolimus in the Treatment of 5 Cases of Blue Rubber Bleb Nevus Syndrome in Children and Literature Review
Systematic Review on Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metabolic Disordersin Children
Drug Utilization Evaluation of Voriconazole for Injection in Children Based on Weighted Technique for Order Preference by Similarity to Ideal Solution Method
Related Author
Wang Peng
Xu Ying
Zhang Xiaoming
Zhang Shaonan
Li Changsong
Li Yunxiang
Li Xiaojing
Sun Canlin
Related Institution
The Second People’ s Hospital of Anhui Wuhu, Anhui Wuhu